Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124339612 | 12433961 | 2 | F | 20160512 | 20160627 | 20160603 | 20160705 | EXP | IT-SA-2016SA103489 | AVENTIS | 77.00 | YR | E | M | Y | 0.00000 | 20160705 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124339612 | 12433961 | 1 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | Y | UNK | 20839 | 75 | MG | FILM-COATED TABLET | QD | |||||
| 124339612 | 12433961 | 2 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Oral | 0 | 25 | MG | TABLET | ||||||||
| 124339612 | 12433961 | 3 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 0 | TABLET | ||||||||||
| 124339612 | 12433961 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Oral | 0 | TABLET | ||||||||||
| 124339612 | 12433961 | 5 | C | GLIMEPIRIDE. | GLIMEPIRIDE | 1 | Oral | 0 | 2 | MG | TABLET | ||||||||
| 124339612 | 12433961 | 6 | C | COLECALCIFEROL | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 124339612 | 12433961 | 7 | C | LERCANIDIPINE | LERCANIDIPINE | 1 | 0 | ||||||||||||
| 124339612 | 12433961 | 8 | C | LOBIVON | NEBIVOLOL HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLET | ||||||||
| 124339612 | 12433961 | 9 | C | LIORESAL | BACLOFEN | 1 | Oral | 0 | 25 | MG | TABLET | ||||||||
| 124339612 | 12433961 | 10 | C | JUMEX | SELEGILINE HYDROCHLORIDE | 1 | Oral | 0 | 5 | MG | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124339612 | 12433961 | 1 | Vascular encephalopathy |
| 124339612 | 12433961 | 2 | Diuretic therapy |
| 124339612 | 12433961 | 3 | Hypercholesterolaemia |
| 124339612 | 12433961 | 4 | Hyperuricaemia |
| 124339612 | 12433961 | 5 | Type 2 diabetes mellitus |
| 124339612 | 12433961 | 7 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124339612 | 12433961 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124339612 | 12433961 | Anaemia | |
| 124339612 | 12433961 | Duodenal ulcer | |
| 124339612 | 12433961 | Haemorrhagic erosive gastritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124339612 | 12433961 | 1 | 20110101 | 20160511 | 0 | |
| 124339612 | 12433961 | 2 | 20160512 | 0 | ||
| 124339612 | 12433961 | 3 | 20160512 | 0 | ||
| 124339612 | 12433961 | 4 | 20160512 | 0 | ||
| 124339612 | 12433961 | 5 | 20160512 | 0 | ||
| 124339612 | 12433961 | 7 | 20160512 | 0 | ||
| 124339612 | 12433961 | 8 | 20160512 | 0 | ||
| 124339612 | 12433961 | 9 | 20160524 | 0 | ||
| 124339612 | 12433961 | 10 | 20160512 | 0 |